Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinsonian Disorders | 2 | 2018 | 77 | 0.620 |
Why?
|
| Trazodone | 1 | 2018 | 6 | 0.570 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2018 | 33 | 0.560 |
Why?
|
| Parkinson Disease | 4 | 2020 | 700 | 0.290 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2022 | 647 | 0.220 |
Why?
|
| Essential Tremor | 1 | 2022 | 91 | 0.170 |
Why?
|
| Veterans | 3 | 2022 | 1731 | 0.170 |
Why?
|
| Brain Concussion | 1 | 2022 | 229 | 0.160 |
Why?
|
| Depression | 2 | 2018 | 1292 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 284 | 0.120 |
Why?
|
| Levodopa | 2 | 2014 | 92 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 6551 | 0.110 |
Why?
|
| Globus Pallidus | 1 | 2013 | 68 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 78 | 0.100 |
Why?
|
| Dystonic Disorders | 1 | 2013 | 95 | 0.090 |
Why?
|
| Age of Onset | 1 | 2014 | 609 | 0.090 |
Why?
|
| Antiparasitic Agents | 1 | 2012 | 27 | 0.090 |
Why?
|
| Patient Admission | 1 | 2012 | 170 | 0.080 |
Why?
|
| Anxiety | 1 | 2015 | 962 | 0.070 |
Why?
|
| Deep Brain Stimulation | 1 | 2013 | 402 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2022 | 1386 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 1838 | 0.050 |
Why?
|
| Male | 6 | 2020 | 62087 | 0.050 |
Why?
|
| Primidone | 1 | 2022 | 9 | 0.050 |
Why?
|
| Propranolol | 1 | 2022 | 111 | 0.040 |
Why?
|
| Humans | 8 | 2022 | 126084 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 726 | 0.040 |
Why?
|
| Aged | 4 | 2020 | 20004 | 0.030 |
Why?
|
| Middle Aged | 4 | 2020 | 27329 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1537 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 111 | 0.030 |
Why?
|
| Muscle Relaxants, Central | 1 | 2013 | 37 | 0.030 |
Why?
|
| Antiparkinson Agents | 1 | 2014 | 65 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 436 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2578 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2013 | 192 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3303 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2013 | 168 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 416 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 790 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 822 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2012 | 35 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 138 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 418 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 297 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 783 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2012 | 333 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16768 | 0.020 |
Why?
|
| Medication Errors | 1 | 2012 | 193 | 0.020 |
Why?
|
| Female | 4 | 2020 | 67913 | 0.020 |
Why?
|
| Telemedicine | 1 | 2015 | 486 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2012 | 330 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2936 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 3905 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5050 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 30253 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12325 | 0.010 |
Why?
|